Zurich Cantonal Bank’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $83.7K | Sell |
5,773
-568
| -9% | -$7.66K | ﹤0.01% | 2423 |
|
|
2026
Q1 | $87.8K | Buy |
+6,341
| New | +$88.3K | ﹤0.01% | 2399 |
|
|
2025
Q4 | – | Sell |
-5,581
| Closed | -$78.3K | – | 3309 |
|
|
2025
Q3 | $78K | Buy |
+5,581
| New | +$80.3K | ﹤0.01% | 2410 |
|
|
2021
Q4 | – | Sell |
-25,450
| Closed | -$332K | – | 2933 |
|
|
2021
Q3 | $332K | Hold |
25,450
| – | – | ﹤0.01% | 1564 |
|
|
2021
Q2 | $374K | Hold |
25,450
| – | – | ﹤0.01% | 1398 |
|
|
2021
Q1 | $312K | Hold |
25,450
| – | – | ﹤0.01% | 1521 |
|
|
2020
Q4 | $363K | Sell |
25,450
-32,500
| -56% | -$438K | ﹤0.01% | 1462 |
|
|
2020
Q3 | $806K | Sell |
57,950
-52,000
| -47% | -$620K | 0.01% | 904 |
|
|
2020
Q2 | $1.17M | Hold |
109,950
| – | – | 0.01% | 761 |
|
|
2020
Q1 | $887K | Sell |
109,950
-82,500
| -43% | -$688K | 0.01% | 770 |
|
|
2019
Q4 | $1.56M | Hold |
192,450
| – | – | 0.01% | 729 |
|
|
2019
Q3 | $1.46M | Sell |
192,450
-88,000
| -31% | -$655K | 0.01% | 726 |
|
|
2019
Q2 | $2.1M | Sell |
280,450
-102,000
| -27% | -$802K | 0.02% | 640 |
|
|
2019
Q1 | $3.1M | Sell |
382,450
-186,500
| -33% | -$1.42M | 0.03% | 518 |
|
|
2018
Q4 | $4.29M | Sell |
568,950
-277,455
| -33% | -$1.95M | 0.04% | 408 |
|
|
2018
Q3 | $5.86M | Sell |
846,405
-505
| -0.1% | -$3.38K | 0.05% | 384 |
|
|
2018
Q2 | $5.45M | Sell |
846,910
-62,500
| -7% | -$394K | 0.05% | 401 |
|
|
2018
Q1 | $5.95M | Sell |
909,410
-125,050
| -12% | -$876K | 0.05% | 380 |
|
|
2017
Q4 | $7.77M | Sell |
1,034,460
-289,000
| -22% | -$2.08M | 0.07% | 324 |
|
|
2017
Q3 | $9.44M | Buy |
1,323,460
+59,915
| +5% | +$431K | 0.09% | 274 |
|
|
2017
Q2 | $10.6M | Buy |
1,263,545
+78,500
| +7% | +$638K | 0.1% | 221 |
|
|
2017
Q1 | $9.52M | Buy |
1,185,045
+26,000
| +2% | +$225K | 0.09% | 244 |
|
|
2016
Q4 | $10.5M | Buy |
1,159,045
+79,545
| +7% | +$740K | 0.11% | 203 |
|
|
2016
Q3 | $10M | Buy |
1,079,500
+75,000
| +7% | +$716K | 0.1% | 212 |
|
|
2016
Q2 | $10.3M | Sell |
1,004,500
-265,000
| -21% | -$2.43M | 0.13% | 161 |
|
|
2016
Q1 | $11.5M | Sell |
1,269,500
-9,800
| -0.8% | -$87.6K | 0.15% | 149 |
|
|
2015
Q4 | $11.8M | Buy |
1,279,300
+32,405
| +3% | +$355K | 0.15% | 145 |
|
|
2015
Q3 | $15.9M | Sell |
1,246,895
-54,470
| -4% | -$677K | 0.22% | 107 |
|
|
2015
Q2 | $14.4M | Sell |
1,301,365
-12,460
| -0.9% | -$138K | 0.2% | 115 |
|
|
2015
Q1 | $15M | Buy |
1,313,825
+604,325
| +85% | +$6.41M | 0.21% | 115 |
|
|
2014
Q4 | $7.16M | Buy |
709,500
+99,000
| +16% | +$1.04M | 0.22% | 104 |
|
|
2014
Q3 | $6.42M | Sell |
610,500
-555,000
| -48% | -$5.22M | 0.21% | 104 |
|
|
2014
Q2 | $10.1M | Sell |
1,165,500
-223,350
| -16% | -$1.88M | 0.3% | 76 |
|
|
2014
Q1 | $12.2M | Buy |
1,388,850
+255,975
| +23% | +$2.23M | 0.38% | 52 |
|
|
2013
Q4 | $9.3M | Sell |
1,132,875
-533,440
| -32% | -$4.22M | 0.3% | 71 |
|
|
2013
Q3 | $12.6M | Buy |
1,666,315
+516,815
| +45% | +$3.76M | 0.44% | 41 |
|
|
2013
Q2 | $8.7M | Buy |
+1,149,500
| New | +$8.39M | 0.3% | 74 |
|
Other funds holding RDY
AIM
Zurich Cantonal Bank's RDY Position: Q2 2026 in Review
Zurich Cantonal Bank reduced its Dr. Reddy's Laboratories (RDY) stake by 9% in Q2 2026, selling an estimated $7.66K and leaving 5,773 shares worth $83.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2423.
Zurich Cantonal Bank first reported a position in RDY in Q2 2013 and has held it in 37 quarters since. The position peaked at $15.9M in Q3 2015. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.
- Zurich Cantonal Bank held 5,773 shares of Dr. Reddy's Laboratories worth $83.7K as of Q2 2026.
- Zurich Cantonal Bank sold 568 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $7.66K.
- Dr. Reddy's Laboratories made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2423 holding.
- Zurich Cantonal Bank first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 37 quarters since.
- Zurich Cantonal Bank's Dr. Reddy's Laboratories position peaked at $15.9M in Q3 2015.
- 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.
Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.